epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Accutane
    isotretinoin
  • remove Alyacen 1/ 35
    norethindrone/ ethinyl estradiol
  • remove Demadex
    torsemide
  • remove Lutera
    levonorgestrel/ ethinyl estradiol
  • remove Metanx
    levomefolate/ Schizochytrium/ pyridoxal phosphate/ methylcobalamin

multicheck MultiCheck Results - 5 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Alyacen 1/35 (norethindrone/ ethinyl estradiol) + Lutera (levonorgestrel/ ethinyl estradiol)

Avoid/Use Alternative


ethinyl estradiol (contraceptive) + ethinyl estradiol (contraceptive)

avoid combo: combo may incr. risk of HTN, thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

norethindrone (contraceptive) + levonorgestrel (contraceptive)

avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

Smiley face Smiley face Alyacen 1/35 (norethindrone/ ethinyl estradiol) + Demadex (torsemide)

Monitor/Modify Tx


ethinyl estradiol (contraceptive) + torsemide

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face Demadex (torsemide) + Lutera (levonorgestrel/ ethinyl estradiol)

Monitor/Modify Tx


torsemide + ethinyl estradiol (contraceptive)

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Caution Advised

Smiley face Smiley face Accutane (isotretinoin) + Demadex (torsemide)

Caution Advised


isotretinoin + torsemide

caution advised: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information